Mohan Paul Singh Ishar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mohan Paul Singh Ishar has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Vishal Sharma
Bio-organic and Photochemistry Laboratory, Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab -143005 India
5 shared publicationsVivek Gupta
Post-Graduate Department of Physics University of Jammu Jammu Tawi 180 006 India
5 shared publicationsGagandeep Singh
Bio-Organic and Photochemistry Laboratory, Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, 143 005, Punjab, India
4 shared publicationsHarpreet Kaur
Department of Microbiology, Guru Nanak Dev University, Amritsar, Punjab -143005 India
4 shared publicationsSaroj Arora
Department of Environmental and Botanical Sciences, Guru Nanak Dev University, Amritsar 143 005, India
4 shared publications- Ashun Chaudhary
Department of Plant Sciences, School of Life Sciences, Central University of Himachal Pradesh, Dharamshala, Kangra, India
3 shared publications
Latest Publications
- 10 January 2024
- Published by Wiley in Chemistry & Biodiversity
- Vol. 21 (2) , e202301323
Facile Synthesis of Some New Peptidomimetic β3‐and β2,3‐Amino Alcohols Possessing Pyridyl Moiety via Reductive Ring Opening of Pyridyl‐isoxazolidines
Regio‐ and stereoselective 1,3‐dipolar cycloadditions of C‐(3‐pyridyl)‐N‐phenylnitrone (2) with variedly substituted dipolarophiles (3, 4) were carried out to obtain substituted pyridyl‐isoxazolidines (5–8). Reductive cleavage of pyridyl‐isoxazolidines (5–8) with ammonium formate, methanol−THF solvents, at ambient temperature, in the presence of Pd/C provided a facile route for the synthesis of β3‐and β2,3‐amino alcohols (9–12), with a substitution pattern having pronounced influence on torsional angles. The obtained compounds (9–12) are valuable scaffolds which can be utilized for peptidomimetics. Thus, the present methodology for reductive opening of isoxazolidine ring avoids the disadvantages of using expensive apparatus and hazards involved in the use of hydrogen gas. The preferential formation of amino‐alcohols in case of bicyclic isoxazolidines (8a–c), which precludes any recyclization is rationalized by DFT calculations.
- 10 January 2024
- Published by Wiley in Chemistry & Biodiversity
- Vol. 21 (2) , e202301323
Facile Synthesis of Some New Peptidomimetic β3‐and β2,3‐Amino Alcohols Possessing Pyridyl Moiety via Reductive Ring Opening of Pyridyl‐isoxazolidines
Regio‐ and stereoselective 1,3‐dipolar cycloadditions of C‐(3‐pyridyl)‐N‐phenylnitrone (2) with variedly substituted dipolarophiles (3, 4) were carried out to obtain substituted pyridyl‐isoxazolidines (5–8). Reductive cleavage of pyridyl‐isoxazolidines (5–8) with ammonium formate, methanol−THF solvents, at ambient temperature, in the presence of Pd/C provided a facile route for the synthesis of β3‐and β2,3‐amino alcohols (9–12), with a substitution pattern having pronounced influence on torsional angles. The obtained compounds (9–12) are valuable scaffolds which can be utilized for peptidomimetics. Thus, the present methodology for reductive opening of isoxazolidine ring avoids the disadvantages of using expensive apparatus and hazards involved in the use of hydrogen gas. The preferential formation of amino‐alcohols in case of bicyclic isoxazolidines (8a–c), which precludes any recyclization is rationalized by DFT calculations.
- 16 November 2016
- Published by Springer Nature in Journal of Chemical Biology
- Vol. 10 (1) , 35-44
2-(chromon-3-yl)imidazole derivatives as potential antimicrobial agents: synthesis, biological evaluation and molecular docking studies
A series of novel 2-(chromon-3-yl)-4,5-diphenyl-1H-imidazoles (4a-h) were synthesized by one pot condensation of substituted 3-formylchromones (1a-h), benzil (2) and ammonium acetate (3) in refluxing acetic acid at 110 °C under N2 atmosphere. Allylation of compounds 4a-h with allyl bromide in the presence of fused K2CO3 furnished N-allyl-2-(chromon-3-yl)-4,5-diphenyl-1H-imidazoles (6a-h). The synthesized compounds were characterized spectroscopically and evaluated for in vitro antimicrobial activity against various pathogenic bacterial and fungal strains by disc diffusion method. Compounds bearing electron withdrawing substituents such as bromo (4f) showed significant inhibitory activity against S. cerevisiae (MIC 1.4 μg/ml) and 4g containing chloro substituent, displayed more inhibitory potential against C. albicans (MIC 1.5), as compared to the standard drugs. Compounds 6a and 4c exhibit remarkable inhibitory potential against B. subtilis with MIC 0.98 and 1.23, respectively. The time kill assay for active compound 6a was performed by viable cell count (VCC) method to elucidate the microbicidal nature of 2-(chromon-3-yl)imidazoles. A molecular docking study of most active compounds with target ‘lanosterol 14α-demethylase’ (CYP51) was performed to unravel the mode of antifungal action.
- 16 November 2016
- Published by Springer Nature in Journal of Chemical Biology
- Vol. 10 (1) , 35-44
2-(chromon-3-yl)imidazole derivatives as potential antimicrobial agents: synthesis, biological evaluation and molecular docking studies
A series of novel 2-(chromon-3-yl)-4,5-diphenyl-1H-imidazoles (4a-h) were synthesized by one pot condensation of substituted 3-formylchromones (1a-h), benzil (2) and ammonium acetate (3) in refluxing acetic acid at 110 °C under N2 atmosphere. Allylation of compounds 4a-h with allyl bromide in the presence of fused K2CO3 furnished N-allyl-2-(chromon-3-yl)-4,5-diphenyl-1H-imidazoles (6a-h). The synthesized compounds were characterized spectroscopically and evaluated for in vitro antimicrobial activity against various pathogenic bacterial and fungal strains by disc diffusion method. Compounds bearing electron withdrawing substituents such as bromo (4f) showed significant inhibitory activity against S. cerevisiae (MIC 1.4 μg/ml) and 4g containing chloro substituent, displayed more inhibitory potential against C. albicans (MIC 1.5), as compared to the standard drugs. Compounds 6a and 4c exhibit remarkable inhibitory potential against B. subtilis with MIC 0.98 and 1.23, respectively. The time kill assay for active compound 6a was performed by viable cell count (VCC) method to elucidate the microbicidal nature of 2-(chromon-3-yl)imidazoles. A molecular docking study of most active compounds with target ‘lanosterol 14α-demethylase’ (CYP51) was performed to unravel the mode of antifungal action.
- 1 October 2016
- Published by Elsevier in Tetrahedron Letters
- Vol. 57 (42) , 4688-4692
Formation and reductive ring opening reactions of indolyl bicyclic-isoxazolidines-II:7 access to novel natural product analogs
- 1 October 2016
- Published by Elsevier in Tetrahedron Letters
- Vol. 57 (42) , 4688-4692
Formation and reductive ring opening reactions of indolyl bicyclic-isoxazolidines-II:7 access to novel natural product analogs
- 7 October 2015
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 87 (2) , 213-223
Chromanyl–isoxazolidines as Antibacterial agents: Synthesis, Biological Evaluation, Quantitative Structure Activity Relationship, and Molecular Docking Studies
Regio‐ and stereoselective 1,3‐dipolar cycloadditions of C‐(chrom‐4‐one‐3‐yl)‐N‐phenylnitrones (N) with different mono‐substituted, disubstituted, and cyclic dipolarophiles were carried out to obtain substituted N‐phenyl‐3′‐(chrom‐4‐one‐3‐yl)‐isoxazolidines (1‐40). All the synthesized compounds were assayed for their in vitro antibacterial activity and display significant inhibitory potential; in particular, compound 32 exhibited good inhibitory activity against Salmonella typhymurium‐1 & Salmonella typhymurium‐2 with minimum inhibitory concentration value of 1.56 μg/mL and also showed good potential against methicillin‐resistant Staphylococcus aureus with minimum inhibitory concentration 3.12 μg/mL. Quantitative structure activity relationship investigations with stepwise multiple linear regression analysis and docking simulation studies have been performed for validation of the observed antibacterial potential of the investigated compounds for determination of the most important parameters regulating antibacterial activities.
- 7 October 2015
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 87 (2) , 213-223
Chromanyl–isoxazolidines as Antibacterial agents: Synthesis, Biological Evaluation, Quantitative Structure Activity Relationship, and Molecular Docking Studies
Regio‐ and stereoselective 1,3‐dipolar cycloadditions of C‐(chrom‐4‐one‐3‐yl)‐N‐phenylnitrones (N) with different mono‐substituted, disubstituted, and cyclic dipolarophiles were carried out to obtain substituted N‐phenyl‐3′‐(chrom‐4‐one‐3‐yl)‐isoxazolidines (1‐40). All the synthesized compounds were assayed for their in vitro antibacterial activity and display significant inhibitory potential; in particular, compound 32 exhibited good inhibitory activity against Salmonella typhymurium‐1 & Salmonella typhymurium‐2 with minimum inhibitory concentration value of 1.56 μg/mL and also showed good potential against methicillin‐resistant Staphylococcus aureus with minimum inhibitory concentration 3.12 μg/mL. Quantitative structure activity relationship investigations with stepwise multiple linear regression analysis and docking simulation studies have been performed for validation of the observed antibacterial potential of the investigated compounds for determination of the most important parameters regulating antibacterial activities.
- 4 August 2015
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 6 (9) , 1626-1634
Induction of apoptosis by cyclobutanones and derived polycyclic γ-lactones: a preliminary analysis of antiproliferative activity
A series of cyclobutanones (7a–f) were synthesized by irradiation of β-ionone derived chalcones (4a–f) in aqueous methanol and further converted to polycyclic γ-lactones (8a–f) by Baeyer–Villiger oxidation.
- 4 August 2015
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 6 (9) , 1626-1634
Induction of apoptosis by cyclobutanones and derived polycyclic γ-lactones: a preliminary analysis of antiproliferative activity
A series of cyclobutanones (7a–f) were synthesized by irradiation of β-ionone derived chalcones (4a–f) in aqueous methanol and further converted to polycyclic γ-lactones (8a–f) by Baeyer–Villiger oxidation.
- Open Access
- 20 January 2015
- Vol. 9 (1) , 59-67
In vivo pharmacological profile of substituted (3-pyridyl)-2-phenylisoxazolidine analogues of nicotine as novel antinociceptives
Nicotinic ligands have been studied as novel therapeutic interventions in pain therapeutics since a long time. Several nicotinic agonists have been withdrawn from later stages of clinical trials due to lack of efficacy or narrow therapeutic window. These have been documented to act in the central nervous system and produce a wide range of pharmacological effects, including memory enhancing and analgesic actions, antianxiety, antidepressant and muscle coordination. Taking cognizance of the wide pharmacological profile of nicotine and its ligands, it was decided to evaluate some novel isoxazolidine analogues of nicotine for their potential as analgesics, using animal models like Eddy's hot plate and Tail immersion method. The compounds showed marked decrease in hyperalgesic response as compared to pentazocine at a wide range of doses. They were well tolerated as none of the compounds was found to have any seizure potential or mortality even at the highest doses. Thus, these compounds can be developed as potent antinociceptives with better safety profile than nicotine and other currently available pain therapeutics.
- 20 January 2015
- Vol. 9 (1) , 59-67
Open AccessIn vivo pharmacological profile of substituted (3-pyridyl)-2-phenylisoxazolidine analogues of nicotine as novel antinociceptives
Nicotinic ligands have been studied as novel therapeutic interventions in pain therapeutics since a long time. Several nicotinic agonists have been withdrawn from later stages of clinical trials due to lack of efficacy or narrow therapeutic window. These have been documented to act in the central nervous system and produce a wide range of pharmacological effects, including memory enhancing and analgesic actions, antianxiety, antidepressant and muscle coordination. Taking cognizance of the wide pharmacological profile of nicotine and its ligands, it was decided to evaluate some novel isoxazolidine analogues of nicotine for their potential as analgesics, using animal models like Eddy's hot plate and Tail immersion method. The compounds showed marked decrease in hyperalgesic response as compared to pentazocine at a wide range of doses. They were well tolerated as none of the compounds was found to have any seizure potential or mortality even at the highest doses. Thus, these compounds can be developed as potent antinociceptives with better safety profile than nicotine and other currently available pain therapeutics.
- 1 November 2014
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 87, 228-236
β-Ionone derived apoptosis inducing endoperoxides; Discovery of potent leads for anticancer agents
- 1 November 2014
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 87, 228-236
β-Ionone derived apoptosis inducing endoperoxides; Discovery of potent leads for anticancer agents
- 1 October 2014
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 24 (19) , 4724-4728
Synthesis and evaluation of 3-salicyloylpyridine derivatives as cytotoxic mitochondrial apoptosis inducers
- 1 October 2014
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 24 (19) , 4724-4728
Synthesis and evaluation of 3-salicyloylpyridine derivatives as cytotoxic mitochondrial apoptosis inducers